Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine
- PMID: 38941310
- PMCID: PMC11213289
- DOI: 10.1371/journal.pone.0306264
Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine
Abstract
Frequent use of pain relief medications among patients with migraine can result in disease worsening and medication-overuse headache (MOH), a painful and debilitating condition. We sought to conduct a cross-sectional survey among adult patients diagnosed with migraine to determine: 1) their awareness of MOH, and 2) their knowledge of the condition and its prevention, and 3) the association of these factors with actual use of pain relief medications. We recruited and interviewed 200 English-speaking adults with migraine who had a clinic visit with a neurologist or primary care provider within the past month. Patients were identified via an electronic health record query. Almost 40% of participants had never heard of the term 'medication-overuse headache.' In bivariate analyses, participants who were Black or Hispanic and those with limited health literacy were less likely to have heard of MOH. Participants scored an average of 2.1 (range: 0-3) on a MOH knowledge measure; older participants, those with limited health literacy, lower education, and little or no migraine-related disability demonstrated less knowledge. Almost a third (31.5%) of patients reported overusing pain relief medication and were at risk for MOH. Overuse was not significantly associated with MOH awareness, knowledge, or sociodemographic factors, but was related to greater migraine-related disability. Our findings suggest that patient awareness and knowledge of MOH is suboptimal, particularly among older adults, racial and ethnic minority groups, and those with limited health literacy. Interventions are needed to prevent MOH and better inform patients about risks associated with frequent use of pain relief medications.
Copyright: © 2024 Bailey et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
SCB reports grants from Merck, Pfizer, Gordon and Betty Moore Foundation, RRF Foundation for Aging, Lundbeck, Gilead and Eli Lilly through her institution; and personal fees from Gilead, Sanofi, Pfizer, University of Westminster, Lundbeck, and Luto outside the submitted work. APP reports grants from Merck, Pfizer, Gordon and Betty Moore Foundation, RRF Foundation for Aging, Lundbeck, Gilead, and Eli Lilly through her institution; and personal fees from Gilead. MPH and DF are employees of H. Lundbeck A/S and Lundbeck LLC, respectively. SMK was an employee of Lundbeck LLC at the time when this manuscript was written. All other study authors have no conflicts of interest to report.
Similar articles
-
Delayed opportunities for patient-provider communication about medication overuse headache: Mixed methods perspectives from patients and neurologists.Prev Med Rep. 2024 Feb 21;40:102659. doi: 10.1016/j.pmedr.2024.102659. eCollection 2024 Apr. Prev Med Rep. 2024. PMID: 38435414 Free PMC article.
-
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.Headache. 2021 Feb;61(2):351-362. doi: 10.1111/head.14056. Epub 2021 Jan 12. Headache. 2021. PMID: 33432635 Clinical Trial.
-
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.BMC Neurol. 2021 Nov 2;21(1):425. doi: 10.1186/s12883-021-02451-x. BMC Neurol. 2021. PMID: 34727873 Free PMC article.
-
Decision-making deficit in chronic migraine patients with medication overuse.Neurol Sci. 2012 May;33 Suppl 1:S151-5. doi: 10.1007/s10072-012-1071-4. Neurol Sci. 2012. PMID: 22644192
-
[Clinical features and mechanisms of chronic migraine and medication-overuse headache].Rinsho Shinkeigaku. 2010 Nov;50(11):990-3. doi: 10.5692/clinicalneurol.50.990. Rinsho Shinkeigaku. 2010. PMID: 21921539 Review. Japanese.
Cited by
-
Low health literacy impact on headache diagnosis.Pain Manag. 2025 Mar;15(3):141-147. doi: 10.1080/17581869.2025.2463874. Epub 2025 Feb 22. Pain Manag. 2025. PMID: 39987468
-
Medication-Overuse Headache: Update on Management.Life (Basel). 2024 Sep 11;14(9):1146. doi: 10.3390/life14091146. Life (Basel). 2024. PMID: 39337929 Free PMC article. Review.
References
-
- Lantéri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50. doi: 10.1177/0333102411398400 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous